🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Unknown
Location
Meander Medisch Centrum
Start Date
2001-02
Trial ID
NCT00028717
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
CCOP - Scottsdale Oncology Program
Start Date
1994-01
Trial ID
NCT00002548
RATIONALE: Drugs used in chemotherapy work in different ways to stop cancer...
Status
Completed
Location
Aurora Presbyterian Hospital
Start Date
1993-05-07
Trial ID
NCT00002514
Treatments Being Tested
This study is open-label, multi-center, prospective study, which targets ch...
Status
Recruiting
Location
Kyungpook National University Chilgok Hospital
Start Date
2024-04-04
Trial ID
NCT05827549
Treatments Being Tested
Study of ONTAK and CHOP (chemotherapy drugs) to find out their ability to m...
Status
Completed
Location
Birmingham Hematology and Oncology
Start Date
2004-03-14
Trial ID
NCT00211185
Treatments Being Tested
This is a randomized, open-label, multi-center, phase 2 study of RCHOP with...
Status
Completed
Location
Tower Cancer Research Foundation
Start Date
2009-10
Trial ID
NCT00931918
Treatments Being Tested
Post-transplantation lymphoproliferative disorder (PTLD) develops in one to...
Status
Terminated
Location
Princess Alexandra Hospital, Ipswich Rd, Woolloongabba, Qld 4102
Start Date
2002-12
Trial ID
NCT01458548
Irinotecan is a commonly used salvage chemotherapy drug for children with r...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2022-01-01
Trial ID
NCT06760117
Treatments Being Tested
This is a phase II prospective non-randomised clinical trial in newly diagn...
Status
Completed
Location
Aarhus University Hospital
Start Date
2001-10
Trial ID
NCT00791947
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab and yttrium Y 90 ibritu...
Status
Completed
Location
Comprehensive Cancer Center at University of Alabama at Birmingham
Start Date
2003-11
Trial ID
NCT00070447